 |
 |

Is the p53 Gene Mutation of Prognostic Value in Hepatocellular Carcinoma?
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
The prognostic value of p53 overexpression in hepatocellular carcinoma (HCC) is controversial. It has been reported that p53 protein overexpression is associated with a poorer prognosis in terms of patients' survival.1 Jeng et al2 report a significant association of p53 overexpression with a more invasive phenotype of the tumor and higher rates of recurrence, but the survival lengths were not significantly affected. In other studies, p53 overexpression in HCC has also been associated with more aggressive behavior of the tumor, poorer cellular differentiation, venous permeation, and intrahepatic metastasis.3 These and other data4-5 imply that p53 overexpression plays a significant role in tumor progression, particularly at a later stage of hepatocarcinogenesis. However, in some reports with either univariate or multivariate analysis,6-7 p53 overexpression in HCC has not been found to have prognostic significance despite the finding that tumors with p53 overexpression often had more malignant characteristics. Interestingly, the controversy of prognostic . . . [Full Text of this Article]
|